Sponsored
Minimising the risk of exacerbations in moderate-to-severe COPD: the pharmacist’s role
Pharmacists can have an important role in supporting their patients manage their COPD medications, inhaler selection and technique, as well as non-pharmacological strategies to help improve quality of life. By …
OMG it’s MGD! The basics of meibomian gland dysfunction and how you can help in the pharmacy
Meibomian gland dysfunction (MGD) is a relatively common condition, especially among those with dry eye. This article describes the many medications or conditions seen in the pharmacy that may be …
Don’t dismiss the importance of formulations in treating atopic eczema
Topical corticosteroids (TCS) have long been a part of atopic eczema management—but how often have you considered the formulation when recommending TCS options to your patients? Watch this webinar to …
Complementary medicines and relief of symptoms of benign prostatic hypertrophy (BPH)
Pharmacists can potentially play a key role in the management of BPH, allowing patients to maximise symptom relief by educating them on all available treatment options. By Tim Stewart, clinical …
Molnupiravir: an oral treatment to add to the COVID-19 arsenal
The Therapeutic Goods Administration (TGA) has granted provisional approval for two new oral medications that are indicated for use in mild-to-moderate COVID-19 infections to prevent disease progression and hospitalisations. What …
The role of pharmacists in managing work-related musculoskeletal disorders
This article discusses the importance of managing work-related musculoskeletal disorders (WMSD) in primary care including the typical features that pharmacists should be aware of. It examines the role of pharmacotherapy …
Sore throat: evidence-based management
The vast majority of sore throats are caused by viruses. Yet pharmacists still tend to recommend lozenges containing antiseptic/antibacterial ingredients with mostly in vitro evidence to support their effectiveness. This …
Antiseizure medication shortages and brand switching in epilepsy
While brand switching in epilepsy is not encouraged, the high prevalence of antiseizure medications shortages, particularly for generic brands, means that avoidance of brand switching is not always possible. In …
Dry eye: a holistic approach to prevention and management in the wake of the COVID-19 pandemic
In this two-part podcast, our expert panel discuss the signs and symptoms of dry eye, its causes and potential risks, including the emergence of ‘quarantine dry eye’ and ‘mask associated …
Why you should discuss flu vaccine choices with your patients this year
With more influenza vaccine options available this year than previously,1 many Australians are keen to discuss their vaccination choices with their pharmacist or GP, according to a survey of one …
Over-the-counter options for reflux: Gaviscon & Guardium
Troublesome symptoms of gastro-oesophageal reflux disease (GORD) affect approximately 14% of adults.1 While symptoms may vary from patient to patient, heartburn and acid regurgitation are the most commonly reported symptoms.2 …
Watch: Don’t dismiss the importance of formulations in treating atopic eczema
How often have you considered the formulation when recommending topical corticosteroids to your patients with atopic eczema? Choosing a TCS formulation that is appropriate for the site and severity of …
APP2022: Recorded CPD sessions brought to you by Reckitt
What should your first choice in back pain oral treatment be? Watch Joyce McSwan and Dr Vincent Chan as they explore what Australian pharmacists are really thinking and doing when it …
5 things to know about LAGEVRIO® (molnupiravir) – an oral antiviral treatment for COVID-19
LAGEVRIO® (molnupiravir) has provisional approval for the treatment of adults with COVID-19 who do not require initiation of oxygen due to COVID-19 and who are at increased risk for hospitalisation …
Webinar: Don’t dismiss the importance of formulations in treating atopic eczema
Topical corticosteroids (TCS) have long been a part of atopic eczema management – but how often have you considered the formulation when recommending TCS options to your patients? Watch this …